Thrice-daily blood pressure readings on sotalol in the treatment of hypertension: once- versus twice-daily regimen

Journal of Clinical Pharmacology
I Parvinen, E Paukkala

Abstract

Thirty patients with mild to severe essential hypertension satisfactorily controlled by twice-daily sotalol therapy entered a double-blind, crossover study comparing the efficacy, tolerability, and safety of their usual twice-daily sotalol administration with the same dosage given once daily. Each double-blind period extended eight weeks, during which blood pressure and pulse rate were recorded by a nurse three times daily on alternate days during the last week of each period in the patients' usual living conditions. Plasma sotalol concentration was measured before the morning dosage of sotalol. No statistically significant differences in the parameters were found between once- and twice-daily sotalol administration using sotalol in daily dosages from 80 to 320 mg. All patients concluded the trial, and no increase in side effects was noted during the once-daily period.

References

May 1, 1977·Clinical Pharmacology and Therapeutics·Y M Traub, J B Rosenfeld
Apr 24, 1976·British Medical Journal·A P Douglas-Jones, J M Cruickshank
Mar 11, 1977·European Journal of Clinical Pharmacology·A LehtonenT Kleimola
Apr 1, 1977·British Journal of Clinical Pharmacology·D G McDewitt, R G Shanks
Jul 3, 1976·British Medical Journal·H L Shaw
Jul 1, 1976·Acta Pharmacologica Et Toxicologica·M AnttilaH Sundquist
Jan 1, 1976·The Journal of International Medical Research·A M HarrisJ A Tweed
Apr 3, 1976·British Medical Journal·H Saarimaa
Dec 15, 1973·British Medical Journal·A J Boakes, B H Boeree
Dec 1, 1974·Postgraduate Medical Journal·P G Gooding, E Berman
Jul 1, 1970·Circulation·H BrooksL Dexter
Sep 1, 1974·Clinical Pharmacology and Therapeutics·H SundquistM Arstila
Jan 1, 1974·European Journal of Clinical Pharmacology·R GuglerH J Dengler
Aug 1, 1968·The American Journal of Cardiology·W S Frankl, L A Soloff

Related Concepts

Diastolic Blood Pressure
Circadian Rhythms
Drug Administration Schedule
Pulse Rate
Hypertensive Disease
Darob

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.